Johnson & Johnson ordered to pay $55 million in talc-powder trial

According to Reuters, Johnson & Johnson (JNJ.N) was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.

Following a three-week trial in Missouri state court, jurors deliberated for about a day before returning a verdict for Gloria Ristesund. She was awarded $5 million in compensatory damages and $50 million in punitive damages.

The Plaintiff, Ms. Ristesund, said she used J&J’s talc-based powder products – which include the well-known Baby Powder and Shower to Shower Powder – on her genitals for decades. She was diagnosed with ovarian cancer and had to undergo a hysterectomy and related surgeries. Her cancer is now in remission.

The verdict followed a $72 million jury award from the same court in February to the family of a woman who died from ovarian cancer after years of using talc powder for feminine hygiene.

Plaintiffs in talc litigation, which is concentrated in Missouri and New Jersey state courts, have accused J&J of failing for years to warn that talc was linked to an increased risk for ovarian cancer. J&J has said it acted properly in developing and marketing the products.

We are lawyers from Michigan that have specialized in environmental cancer and defective products cases for more than forty years. If you or a family member suspect that the diagnosis of ovarian cancer could have been the result of exposure to Johnson and Johnson talc products, please feel free to contact us at 248-647-6966.

This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.